High‐throughput detection of antibodies targeting the SARS‐CoV ‐2 Spike in longitudinal convalescent plasma samples-Reference-Cited by-同舟云学术

High‐throughput detection of antibodies targeting the SARS‐CoV ‐2 Spike in longitudinal convalescent plasma samples

Published:2021-02-18 Issue:5 Volume:61 Page:1377-1382
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Anand Sai Priya¹²,Prévost Jérémie¹³,Richard Jonathan¹³,Perreault Josée⁴,Tremblay Tony⁴,Drouin Mathieu⁴,Fournier Marie‐Josée⁴,Lewin Antoine⁴^ORCID,Bazin Renée⁴,Finzi Andrés¹²³^ORCID

Affiliation:

1. Centre de Recherche du CHUM Montréal Quebec Canada

2. Department of Microbiology and Immunology McGill University Montréal Quebec Canada

3. Département de Microbiologie, Infectiologie et Immunologie Université de Montréal Montréal Quebec Canada

4. Héma‐Québec, Affaires Médicales et Innovation Montréal and Québec City Quebec Canada

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.16318

Reference24 articles.

1. Use of convalescent plasma therapy in SARS patients in Hong Kong

2. Effectiveness of convalescent plasma therapy in severe COVID-19 patients

3. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma

4. Treatment with convalescent plasma for COVID‐19 patients in Wuhan, China

5. Use of convalescent plasma in hospitalized patients with COVID-19: case series

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiplexed flow cytometric approach for detection of anti-SARS-CoV-2 IgG, IgM and IgA using beads covalently coupled to the nucleocapsid protein;Letters in Applied Microbiology;2022-06-01

2. Seroprevalence of SARS-CoV-2 antibodies among blood donors in Québec: an update from a serial cross-sectional study;Canadian Journal of Public Health;2022-04-05

3. Standardization of a flow cytometry SARS-CoV-2 serologic test;Cytotechnology;2022-01-03

4. Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between doses;Cell Host & Microbe;2022-01

5. Evaluating Humoral Immunity against SARS-CoV-2: Validation of a Plaque-Reduction Neutralization Test and a Multilaboratory Comparison of Conventional and Surrogate Neutralization Assays;Microbiology Spectrum;2021-12-22